Gubra A/S

kr 302.40As of Sun 8 Nov 2026, 12:00 UTC
CPH:GUBRAHealthcare
Country Denmark
PE (Fwd) •••
TSR 4Y CAGR 38.47%
Div yield —
ROE (16.12%)
Biotechnology
Beta (5Y) 0.48
PE TTM —
TSR TTM (29.61%)
Mkt cap kr 4.966B
ROIC (59.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 336
11.01%
(98.29%)
Hold 11|2|10|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
5.50
5.90
6.05
6.28
19.71%
16.63%
22.75%
14.75%
Revenuekr M
271.4
287.5
289.8
302.4
(2.17%)
5.70%
3.28%
9.01%
Peers (US$740.4M)
Cap (US$)
PE
8.031B
39.82x
2.720B
12.41x
2.365B
6.044x
Capital
TTM
5Y
10Y
Leveragex
5.421
0.059
0.060
EBIT/Intx
1.864
0.153
0.129
Own earn%
340.73
13.71
9.90
Sh yield%
43.78
17.81
17.69
Owners
Insiders/Inst%
5.00
65.22
Short interest%
0.72
SBC / revenue%
5.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
2